Hypothermic Donor Organ Preservation Provider Paragonix Announces First-in-Human Use of Investigational NRP-DCD Method Using SherpaPak by University of Nebraska Medical Center

CAMBRIDGE, MASSACHUSETTS – December 8, 2021 – Paragonix Technologies, a hypothermic donor organ preservation provider, announced the first-in-human clinical use of the investigational NRP-DCD Method by the University of Nebraska Medical Center to recover a donor heart and transport it utilizing the Paragonix SherpaPak® System.

From CathLab Digest

This novel method to advance heart transplantation utilizing DCD (donation after circulatory death) donors is  an innovative combination of proven techniques developed by the University of Nebraska Medical Center to increase  the distance DCD donor organs can travel, thus increasing the potential donor pool. 

In a recovery led by Dr. Marian Urban, the Nebraska team successfully recovered and transported a donor heart with  a cold ischemic time of 156 minutes from a distant site of donation to the Nebraska Medical Center, where a 65-year old male suffering from ischemic cardiomyopathy was successfully transplanted with the organ. The patient, critically  ill and on the waiting list, was able to secure a matching donor sooner than expected because of the ability to utilize  this heart as a result of DCD donation.  

Read the full article at – Hypothermic Donor Organ Preservation Provider Paragonix Announces First-in-Human Use of Investigational NRP-DCD Method Using SherpaPak by University of Nebraska Medical Center